
InsB 9-23
CAS No. ——
InsB 9-23( Insulin B chain (9-23) )
Catalog No. M29825 CAS No. ——
InsB (9-23) is an insulin B-chain peptide that binds to a class II histocompatibility complex (MHC) allele called I-Ag7.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameInsB 9-23
-
NoteResearch use only, not for human use.
-
Brief DescriptionInsB (9-23) is an insulin B-chain peptide that binds to a class II histocompatibility complex (MHC) allele called I-Ag7.
-
DescriptionInsB (9-23) is an insulin B-chain peptide that binds to a class II histocompatibility complex (MHC) allele called I-Ag7.
-
In Vitro——
-
In Vivo——
-
SynonymsInsulin B chain (9-23)
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1645.9
-
Molecular FormulaC72H116N20O22S1
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Ser}{His}{Leu}{Val}{Glu}{Ala}{Leu}{Tyr}{Leu}{Val}{Cys}{Gly}{Glu}{Arg}{Gly}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Georgia Fousteri, et al. InsB:9-23 peptide-based immunotherapy for type 1 diabetes; the immunization frequency and the state of the disease can alter the efficacy. Immunology. 2008 Apr.
molnova catalog



related products
-
Ralinepag
Ralinepag is a potent, orally bioavailable and non-prostanoid prostacyclin (IP) receptor agonist, with EC50s of 8.5 nM, 530 nM and 850 nM for human and rat IP receptor and human DP1 receptor, respectively.
-
Zamaporvint
Zamaporvint (RXC004) is a selective, orally active and potent inhibitor of the Wnt pathway that acts on the membrane-bound fatty acyltransferase porcupine to block Wnt ligand palmitoylation, secretion, and pathway activation.
-
TPCK
TPCK is an irreversible inhibitor of chymotrypsin-like proteases that affect cell proliferation apoptosis and tumorigenesis.